Exjade and Pancreatitis - a phase IV clinical study of FDA data

Summary:

Pancreatitis is found among people who take Exjade, especially for people who are female, 10-19 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Exjade and have Pancreatitis. It is created by eHealthMe based on reports of 29,150 people who have side effects when taking Exjade from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Dec, 08, 2022

29,150 people reported to have side effects when taking Exjade.
Among them, 108 people (0.37%) have Pancreatitis.

What is Exjade?

Exjade has active ingredients of deferasirox. It is often used in iron overload. eHealthMe is studying from 29,188 Exjade users for its effectiveness, alternative drugs and more.

What is Pancreatitis?

Pancreatitis (inflammation of pancreas) is found to be associated with 2,639 drugs and 1,928 conditions by eHealthMe.

Number of Exjade and Pancreatitis reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Exjade and have Pancreatitis?

Check whether Pancreatitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Sirkeci, ?., Sirkeci, E. E., & Ta?el, B. , "Rivaroxaban-induced acute pancreatitis", The European Research Journal, 2018 Jan .
Díaz-García JD, Gallegos-Villalobos A, Gonzalez-Espinoza L, Sanchez-Ni?o MD, Villarrubia J, Ortiz A, "Deferasirox nephrotoxicity [mdash] the knowns and unknowns", Nature reviews nephrology, 2014 Oct .
Liao, K. F., Huang, P. T., Lin, C. C., Lin, C. L., & Lai, S. W., "Fluvastatin use and risk of acute pancreatitis: a population-based case-control study in Taiwan", Biomedicine, 2014 Jan .
Riva A, "Comment on: A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Expert opinion on drug safety, 2013 Sep .
Riva A, "Deferasirox's toxicity", The Lancet, 2013 Jul .
Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
Das S, Mondal S, Dey JK, Bandyopadhyay S, Saha I, Tripathi SK, "A case of montelukast induced hypercholesterolemia, severe hypertriglyceridemia and pancreatitis", Journal of Young Pharmacists, 2013 Jun .
Kontoghiorghes GJ, "Turning a blind eye to deferasirox's toxicity?", The Lancet, 2013 Apr .
Kontoghiorghes GJ, "A record number of fatalities in many categories of patients treated with deferasirox: loopholes in regulatory and marketing procedures undermine patient safety and misguide public funds?", Taylor & Francis, 2013 Jan .

Related studies

How severe was Pancreatitis and when was it recovered:

Pancreatitis in Exjade

Expand to all the drugs that have ingredients of deferasirox:

Pancreatitis and drugs with ingredients of deferasirox (112 reports)

Alternative drugs to, pros and cons of Exjade:

Exjade (29,188 reports)

Common Exjade side effects:

Death: 5,522 reports
Diarrhea: 3,398 reports
Fever: 2,104 reports
Pneumonia: 1,837 reports
Malaise (a feeling of general discomfort or uneasiness): 1,633 reports

Browse all side effects of Exjade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Pancreatitis treatments and more:

Pancreatitis (56,662 reports)

COVID vaccines that are related to Pancreatitis:

Common drugs associated with Pancreatitis:

All the drugs that are associated with Pancreatitis:

Pancreatitis (2,639 drugs)

Common conditions associated with Pancreatitis:

Type 2 diabetes: 5,528 reports
Diabetes: 3,048 reports
High blood pressure: 2,706 reports
Depression: 2,134 reports
Rheumatoid arthritis: 1,792 reports

All the conditions that are associated with Pancreatitis:

Pancreatitis (1,928 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on deferasirox (the active ingredients of Exjade) and Exjade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.